This panel included proteins associated with EMT induction (Vimentin-pSer56, NFκB p100/p52 and IKKε-pSer172) or drug metabolism (CYP1B1), which are also known to induce drug resistance to DTX and PTX in cancer cells [82, 83] (Table 2). The gene discussed is CYP1B1; the disease is cancer.